REBEKAH SALISBURY: Open Payments
NPI 1558910521 · RANDOLPH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$343 in 20 payments from 9 companies in 2025. Trend: 2023 $91 · 2024 $315 · 2025 $343
Food & beverage: $343
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $65 |
| PFIZER INC. | 4 | $64 |
| Lilly USA, LLC | 2 | $33 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Dexcom, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Bausch Health US, LLC | 1 | $16 |
Products named: TRINTELLIX, Ozempic, MOUNJARO, ELIQUIS, ZORYVE, PREVNAR 20, Dexcom G6 Transmitter, Wegovy.
Industry payments across NJ — which companies pay providers there.
